| HOME >> BIOLOGY >> TECHNOLOGY |
per share $0.55 $0.00 $0.98 $0.46
Shares used in
computing basic
earnings per share 32,649,799 32,153,835 32,336,314 32,113,301
Shares used in
computing diluted
earnings per share 32,975,155 32,341,835 32,593,125 32,343,015
Unaudited Condensed Consolidated Balance Sheets Data
October 31, October 31,
2007 2006
Assets:
Cash, cash equivalents and short-term
investments $21,648 $26,828
Accounts receivable, net 41,643 32,746
Inventories, net 109,409 112,320
Other current assets 8,237 8,893
Property, plant and equipment, net 277,915 286,922
Deferred tax asset 51,306 42,800
Goodwill and other, net 86,537 87,464
Total assets $596,695 $597,973
Liabilities and stockholders' equity:
Current liabilities $46,141 $49,786
Non-current liabilities 18,827 55,612
Stockholders' equity 531,727 492,575
Total liabilities and stockholders' equity $596,695 $597,973
Unaudited Condensed Consolidated Cash Flow Data
Year ended October 31,
2007 2006
Operating activities:
Net income $32,013 $14,938
Non-cash items 31,70
'/>"/>
| SOURCE Martek Biosciences Corporation Copyright©2007 PR Newswire. All rights reserved |